David Apelian

EVP and Chief Medical Officer, ACHILLION PHARMACEUTICALS INC.

Companies

Eiger BioPharmaceuticals, Inc.Chief executive officer Feb 2, 2023 to Jul 6, 2023¹
Eiger BioPharmaceuticals, Inc.Board member Jun 20, 2017 to Jul 6, 2023²
Eiger BioPharmaceuticals, Inc.Chief operating officer Jan 9, 2018 to Mar 26, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Eiger BioPharmaceuticals, Inc.11,000 shares⁴Aug 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 16, 2022Sold 5,000 shares at $9.81 of Eiger BioPharmaceuticals, Inc.⁴
Mar 11, 2022Granted 6,000 shares of Eiger BioPharmaceuticals, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREiger BioPharmaceuticals, Inc., Chief executive officer
2
SEC EDGAREiger BioPharmaceuticals, Inc., Board member
3
SEC EDGAREiger BioPharmaceuticals, Inc., Chief operating officer
4
SEC EDGAREiger BioPharmaceuticals, Inc. shares after the filing of Aug 16, 2022
5
SEC EDGARForm 4 filed Mar 11, 2022